Current Neuro-Oncology

Volume 25 Number 5
15 March 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 5, 15 March

Królicki L, Kunikowska J, Bruchertseifer F, Kuliński R, Pawlak D, Koziara H, Rola R, Morgenstern A, Merlo A.
Locoregional Treatment of Glioblastoma With Targeted α Therapy: [213Bi]Bi-DOTA-Substance P Versus [225Ac]Ac-DOTA-Substance P-Analysis of Influence Parameters.
Clin Nucl Med. 2023 Mar 1
. doi: 10.1097/RLU.0000000000004608. PMID: 36854309. Observational study˰ ˍ


Nematollahi-Mahani SN, Ganjalikhan-Hakemi S, Abdi Z.
The Regression of Glioblastoma Multiforme is Time Dependent in the Wild-type Rat Xenograft Model.
Basic Clin Neurosci. 2023 Mar 1;14(2):263-272∟. doi: 10.32598/bcn.2021.3370.1∟. PMID: 38107534∟. Laboratory investigation. ˍ

Bergengruen PM, Hernaíz Driever P, Budach V, Zips D, Grün A.
Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma : A case study.
Strahlenther Onkol. 2023 Mar 2
. doi: 10.1007/s00066-023-02057-x. PMID: 36862153. Case report. ˍ

Kaisman-Elbaz T, Xiao T, Grabowski MM, Barnett GH, Mohammadi AM.
The Impact of Extent of Ablation on Survival of Patients With Newly Diagnosed Glioblastoma Treated With Laser Interstitial Thermal Therapy: A Large Single-Institutional Cohort.
Neurosurgery. 2023 Mar 2
. doi: 10.1227/neu.0000000000002430. PMID: 36861990. Observational study˰ ˍ

Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ, Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM, Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow JE, Kizilbash SH, Tortorelli S, Burns TC.
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas.
medRxiv [Preprint]. 2023 Mar 2:2023.03.01.23286412. doi: 10.1101/2023.03.01.23286412. PMID: 36909488. Laboratory investigation. ˍ

Said MM, Broen MPG, Swart EL, Bartelink IH, Kouwenhoven MCM.
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
Cancers (Basel). 2023 Mar 2;15(5):1561. doi: 10.3390/cancers15051561. PMID: 36900352. Editorial. ˍ

Zhang W, Jiang J, Kang X, Wang C, Chen F, Zhang B, Li S, Huang S, Li W.
Dietary B vitamins and glioma: A case-control study based on Chinese population.
Front Nutr. 2023 Mar 2;10:1122540. doi: 10.3389/fnut.2023.1122540. PMID: 36937346. Observational study. ˍ

Zhang W, He Y, Kang X, Wang C, Chen F, Kang Z, Yang S, Zhang R, Peng Y, Li W.
Association between dietary minerals and glioma: A case-control study based on Chinese population.
Front Nutr. 2023 Mar 2;10:1118997. doi: 10.3389/fnut.2023.1118997. PMID: 36937365. Observational study. ˍ

Azad TD, Kalluri AL, Hansen LJ, Ammar A, Cohen AR.
H3 K27-altered diffuse midline glioma presenting as massive cerebellopontine hemorrhage.
Childs Nerv Syst. 2023 Mar 3
. doi: 10.1007/s00381-023-05904-5. PMID: 36867241. Case report˰ ˍ

Gong M, Fan X, Yu H, Niu W, Sun S, Wang H, Chen X.
Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation.
Mol Neurobiol. 2023 Mar 3
. doi: 10.1007/s12035-023-03288-w. PMID: 36867344. Laboratory investigation˰ ˍ

Schmidt S, Kovacs E, Usta D, Behnisch R, Sahm F, Haux D, Witt O, Milde T, Unterberg A, El Damaty A.
Cerebellar mutism syndrome following posterior fossa tumor surgery in children - a retrospective single center study.
World Neurosurg. 2023 Mar 3:S1878-8750(23)00268-1
. doi: 10.1016/j.wneu.2023.02.117. PMID: 36871657. Observational study˰ ˍ

Silva JA, Colquhoun A.
Effect of Polyunsaturated Fatty Acids on Temozolomide Drug-Sensitive and Drug-Resistant Glioblastoma Cells.
Biomedicines. 2023 Mar 4;11(3):779. doi: 10.3390/biomedicines11030779. PMID: 36979758. Laboratory investigation. ˍ

Yao J, Li S, Cui Q, Ren Y, Li M, Wang J, Zeng M, Ji N, Peng Y, Sessler DI.
Intraoperative hypotension and postoperative stroke in older patients who had brain tumour resections: a retrospective cohort analysis.
World Neurosurg. 2023 Mar 4:S1878-8750(23)00284-X. doi: 10.1016/j.wneu.2023.02.136. PMID: 36878404. Observational study˰ ˍ

Łach K, Kowal A, Perek-Polnik M, Jakubczyk P, Arthur CJ, Bal W, Drogosiewicz M, Dembowska-Bagińska B, Grajkowska W, Cebulski J, Chaber R.
Infrared Spectroscopy as a Potential Diagnostic Tool for Medulloblastoma.
Molecules. 2023 Mar 5;28(5):2390. doi: 10.3390/molecules28052390. PMID: 36903631. Observational study. ˍ


Stoyanov GS, Petkova L, Iliev B, Ali M, Toncheva B, Georgiev R, Tonchev T, Enchev Y.
Extracranial Glioblastoma Metastasis: A Neuropathological Case Report.
Cureus. 2023 Mar 5;15(3):e35803. doi: 10.7759/cureus.35803. PMID: 37025749. Case report. ˍ

Henriksen KA, Von Oettingen G, Skjøth-Rasmussen J, Mathiasen R, Foss-Skiftesvik J.
Assessment of the Milan Complexity Scale for prediction of postoperative morbidity in pediatric neuro-oncological surgery.
Childs Nerv Syst. 2023 Mar 6. doi: 10.1007/s00381-023-05902-7. PMID: 36877208. Observational study˰ ˍ

Jatana S, Mohammad AH, Al-Saadi TD, Carias M, Guevara-Moriones N, Ruiz-Barrera MA, Mindru CS, Diaz RJ.
Characterization of perioperative glycemic status and dexamethasone use with associated postoperative complications in glioblastoma patients.
Acta Neurochir (Wien). 2023 Mar 6. doi: 10.1007/s00701-023-05541-6. PMID: 36879101. Observational study˰ ˍ

More S, Naiker T, Jacobs N, Oompie F, Prasad V.
Short-Interval, Low-Dose [177Lu]Lu-Prostate-Specific Membrane Antigen in the Treatment of Refractory Glioblastoma.
Clin Nucl Med. 2023 Mar 6. doi: 10.1097/RLU.0000000000004612. PMID: 36881610. Case report˰ ˍ

Trifiletti DM, Akinyelu T, Burri SH, Jeudy A, Quinones-Hinojosa A, Prabhu RS.
Glioma inadvertently treated with preoperative stereotactic radiosurgery: focusing on safety.
J Neurooncol. 2023 Mar 6. doi: 10.1007/s11060-023-04278-7. PMID: 36877383. Case report˰ ˍ

Ajuyah P, Mayoh C, Lau LMS, Barahona P, Wong M, Chambers H, Valdes-Mora F, Senapati A, Gifford AJ, D'Arcy C, Hansford JR, Manoharan N, Nicholls W, Williams MM, Wood PJ, Cowley MJ, Tyrrell V, Haber M, Ekert PG, Ziegler DS, Khuong-Quang DA.
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes.
Sci Rep. 2023 Mar 7;13(1):3775. doi: 10.1038/s41598-023-30395-4. PMID: 36882456. Case report, Interventional study. ˍ

Friker LL, Tzaridis T, Enkirch SJ, Lüders C, Hattingen E, Kristiansen G, Goschzik T, Waha A, Lütter C, Weller J, Herrlinger U, Pietsch T, Gessi M, Baumert BG, Gielen GH.
Gliosarcoma with extensive extracranial metastatic spread and familial coincidence: A case report.
Pathol Res Pract. 2023 Mar 7;244:154399. doi: 10.1016/j.prp.2023.154399. PMID: 36905695. Case report˰ ˍ

Kaneoka A, Fujimoto SH, Tamura K, Inaji M, Maehara T.
Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study.
Discov Oncol. 2023 Mar 7;14(1):30. doi: 10.1007/s12672-023-00632-3. PMID: 36881187. Observational study. ˍ

Pace A, Belleudi V, Tanzilli A, Villani V, Poggi FR, Benincasa D, Davoli M, Pinnarelli L.
Pattern of care of brain tumor patients in the last months of life: analysis of a cohort of 3045 patients in the last 10 years.
Neurol Sci. 2023 Mar 7. doi: 10.1007/s10072-023-06722-y. PMID: 36882595. Observational study˰ ˍ

Kang Z, Li S, Lin Y, Li Y, Mao Y, Zhang J, Lei T, Wang H, Su Y, Yang Y, Qiu J, Li W.
A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors.
Invest New Drugs. 2023 Mar 8. doi: 10.1007/s10637-022-01325-4. PMID: 36884148. Interventional study. ˍ


Ermiş E, Althaus A, Blatti M, Uysal E, Leiser D, Norouzi S, Riggenbach E, Hemmatazad H, Ahmadli U, Wagner F.
Therapy Resistance of Glioblastoma in Relation to the Subventricular Zone: What Is the Role of Radiotherapy?
Cancers (Basel). 2023 Mar 9;15(6):1677. doi: 10.3390/cancers15061677. PMID: 36980563. Observational study. ˍ

Huang V, Rejimon A, Reddy K, Trivedi AG, Ramesh KK, Giuffrida AS, Muiruri R, Shim H, Eaton BR.
Spectroscopic MRI-Guided Proton Therapy in Non-Enhancing Pediatric High-Grade Glioma.
Tomography. 2023 Mar 9;9(2):633-646. doi: 10.3390/tomography9020051. PMID: 36961010. Observational study. ˍ

Valvi S, Dun MD, Hansford JR.
National brain tumour registry: a new era of research collaboration with China.
Lancet Reg Health West Pac. 2023 Mar 9;34:100739. doi: 10.1016/j.lanwpc.2023.100739. PMID: 37283976. Comment. ˍ
REFERS TO: Xiao D, et al., National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020. Lancet Reg Health West Pac. 2023 Feb 21;34:100715. doi: 10.1016/j.lanwpc.2023.100715. PMID: 37283963. Observational study. ˍ

Champeaux-Depond C, Jecko V, Weller J, Constantinou P, Tuppin P, Metellus P.
Newly-diagnosed high grade glioma surgery with carmustine wafers implantation. A long-term nationwide retrospective study.
World Neurosurg. 2023 Mar 10:S1878-8750(23)00311-X. doi: 10.1016/j.wneu.2023.03.015. PMID: 36906091. Observational study˰ ˍ

Fuentes-Fayos AC, G-García ME, Pérez-Gómez JM, Montero-Hidalgo AJ, Martín-Colom J, Doval-Rosa C, Blanco-Acevedo C, Torres E, Toledano-Delgado Á, Sánchez-Sánchez R, Peralbo-Santaella E, Ortega-Salas RM, Jiménez-Vacas JM, Tena-Sempere M, López M, Castaño JP, Gahete MD, Solivera J, Luque RM.
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
EBioMedicine. 2023 Mar 10;90:104484. doi: 10.1016/j.ebiom.2023.104484. PMID: 36907105. Laboratory investigation, Observational study. ˍ

He X, Guo Y, Yu C, Zhang H, Wang S.
Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression.
Front Immunol. 2023 Mar 10;14:1097880. doi: 10.3389/fimmu.2023.1097880. PMID: 36969175. Laboratory investigation. ˍ

Liu A, Aboud O, Dahabiyeh LA, Bloch O, Fiehn O.
A pilot study on metabolomic characterization of human glioblastomas and patient plasma.
Res Sq [Preprint]. 2023 Mar doi: 10.21203/ PMID: 36945517. Interventional study. ˍ

Shiba Y, Motomura K, Taniguchi R, Kurimoto M, Mizutani K, Ohka F, Aoki K, Ito E, Nishikawa T, Yamaguchi J, Kibe Y, Shimizu H, Maeda S, Nakashima T, Suzuki H, Muramatsu H, Takahashi Y, Saito R.
Efficacy and safety of bevacizumab, irinotecan, and temozolomide combination for relapsed or refractory pediatric central nervous system embryonal tumor: a single-institution study.
J Neurosurg Pediatr. 2023 Mar 10:1-9. doi: 10.3171/2023.1.PEDS22345. PMID: 36905668. Observational study˰ ˍ


Hou Z, Wu H, Luo N, Li S, Zhang X, Dong S, Zhu D, Zhang H, Tao R.
Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation.
Oncologist. 2023 Mar 13:oyac280. doi: 10.1093/oncolo/oyac280. PMID: 36913260. Case report. ˍ

Sharma M, McKenzie GW, Gaskins J, Yusuf M, Woo S, Mistry AM, Williams BJ.
Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis.
J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04286-7? PMID: 36913046. Observational study˰ ˍ

Zimmermann JSM, Fousse M, Juhasz-Böss I, Radosa JC, Solomayer EF, Mühl-Benninghaus R.
Neurologic Consultations and Headache during Pregnancy and in Puerperium: A Retrospective Chart Review.
J Clin Med. 2023 Mar 13;12(6):2204. doi: 10.3390/jcm12062204. PMID: 36983206. Observational study. ˍ

Duy Hung N, Duy Linh N, Ha Vi N, Van Anh NT, Dinh Hieu N, Dai Ha D, Minh Duc N.
Predictive Value of Preoperative Diffusion Tensor Imaging for Evaluating Postoperative Outcomes of Supratentorial Glioma in the Motor Function Area.
Ther Clin Risk Manag. 2023 Mar 14;19:269-278. doi: 10.2147/TCRM.S402622. PMID: 36941979. Observational study. ˍ

Guo X, Shi Y, Liu D, Li Y, Chen W, Wang Y, Wang Y, Xing H, Xia Y, Li J, Wu J, Liang T, Wang H, Liu Q, Jin S, Qu T, Guo S, Li H, Yang T, Zhang K, Wang Y, Ma W.
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors.
Front Oncol. 2023 Mar 14;13:1131642. doi: 10.3389/fonc.2023.1131642. PMID: 36998447. Observational study. ˍ

Pearl H, Fleischer CC.
Association between altered metabolism and genetic mutations in human glioma.
Cancer Rep (Hoboken). 2023 Mar 14:e1799. doi: 10.1002/cnr2.1799. PMID: 36916606. Laboratory investigation. ˍ

Wu HW, Wu CH, Lin SC, Wu CC, Chen HH, Chen YW, Lee YY, Chang FC.
MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
Cancer Med. 2023 Mar 14. doi: 10.1002/cam4.5780. PMID: 36916326. Observational study. ˍ

Bleeker L, Kouwenhoven MCM, de Heer I, Lissenberg-Witte BI, Gijsbers AH, Dubbink HJ, Kros JM, Gijtenbeek JMM, Kurt E, van der Rijt CCD, Swaak-Kragten AT, de Vos FY, van der Weide HL, French PJ, van den Bent MJ, Wesseling P, Bromberg JEC.
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
J Neurooncol. 2023 Mar 15. doi: 10.1007/s11060-023-04285-8. PMID: 36920679. Observational study. ˍ

Chehade G, Lawson TM, Lelotte J, Daoud L, Di Perri D, Whenham N, Duprez T, Tajeddine N, Tissir F, Raftopoulos C.
Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics.
Acta Neurochir (Wien). 2023 Mar 15
. doi: 10.1007/s00701-023-05544-3. PMID: 36920664. Observational study˰ ˍ

Sharma M, Do TH, Palzer EF, Huling JD, Chen CC.
Comparable safety profile between neuro-oncology procedures involving stereotactic needle biopsy (SNB) followed by laser interstitial thermal therapy (LITT) and LITT alone procedures.
J Neurooncol. 2023 Mar 15. doi: 10.1007/s11060-023-04275-w(?). PMID: 36920678. Observational study˰ ˍ